Prodromal non-motor symptoms of Parkinson’s disease

References

• AbbottRDPetrovitchHWhiteLR2001Frequency of bowel movements and the future risk of Parkinson’s diseaseNeurology574566211502913
   PubMed Web of Science ®Google Scholar
• AbbottRDRossGWWhiteLR2005Excessive daytime sleepiness and subsequent development of Parkinson’s diseaseNeurology651442616275833
   PubMed Web of Science ®Google Scholar
• AbeTIsobeCMurataT2003Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson’s diseaseNeurosci Lett336105812499051
   PubMed Web of Science ®Google Scholar
• AnsariKAJohnsonA1975Olfactory dysfunction in patients with Parkinson’s diseaseJ Chronic Dis2849371176578
   PubMedGoogle Scholar
• BannisterRMathiasCJMathiasCJBannisterR1999Clinical features and evaluation of primary chronic autonomic failure syndromesAutonomic failure4th ed OxfordOxford Univ. Pr30716
   Google Scholar
• BarbantiPFabbriniGRicciA1999Increased expression of dopamine receptors on lymphocytes in Parkinson’s diseaseMov Disord147647710495037
   PubMed Web of Science ®Google Scholar
• BeckerGSeufertJBogdahnU1995Degeneration of substantia nigra in chronic Parkinson‘s disease visualized by transcranial color-coded real-time sonographyNeurology4518247824114
   PubMed Web of Science ®Google Scholar
• BehnkeSBergDNaumannM2005Differentiation of Parkinson‘s disease and atypical parkinsonian syndromes by transcranial ultrasoundJ Neurol Neurosurg Psychiatry76423515716540
   PubMed Web of Science ®Google Scholar
• BenarrochEEMathiasCJBannisterR1999Central neurotransmitters and neuromodulators in cardiovascular regulationAutonomic failure4th edOxfordOxford Univ. Pr3744
   Google Scholar
• BergDBeckerGZeilerB1999Vulnerability of the nigrostriatal system as detected by transcranial ultrasoundNeurology5310263110496262
   PubMed Web of Science ®Google Scholar
• BergDSiefkerCBeckerG2001Echogenicity of the substantia nigra in Parkinson‘s disease and its relation to clinical findingsJ Neurol8684911569897
   PubMed Web of Science ®Google Scholar
• BergDRoggendorfWSchroderU2002Echogenicity of the substantia nigra:association with increased iron content and marker for susceptibility to nigrostriatal injuryArch Neurol59999100512056937
   PubMedGoogle Scholar
• BonifatiVOostraBAHeutinkP2004Unraveling the pathogenesis of Parkinson’s disease—the contribution of monogenic formsCell Mol Life Sci6117295015241550
   PubMed Web of Science ®Google Scholar
• BraakHDel TrediciKRubU2003Staging of brain pathology related to sporadic Parkinson’s diseaseNeurobiol Aging2419721112498954
   PubMed Web of Science ®Google Scholar
• BraakHGhebremedhinERubU2004Stages in the development of Parkinson‘s disease-related pathologyCell Tissue Res3181213415338272
   PubMed Web of Science ®Google Scholar
• BurgutFTBenaurMHencliffeC2006Late-life depression:a neuropsychiatric approachExpert Rev Neurother6657216466313
   PubMed Web of Science ®Google Scholar
• BurnsDJMarkMHPlayfordED1992Parkinson’s disease in twins studied with 18F-dopa and positron emission tomographyNeurology4218949001407569
   PubMed Web of Science ®Google Scholar
• BurnsDJ2002Beyond the iron mask:towards better recognition and treatment of depression associated with Parkinson’s diseaseMov Disord174455412112190
   PubMed Web of Science ®Google Scholar
• CalneDBLangstonJWMartinWR1985Positron emission tomography after MPTP:observations relating to the cause of Parkinson’s diseaseNature31724683876510
   PubMed Web of Science ®Google Scholar
• CarontiBTandaGCalderaroC1999Reduced dopamine in peripheral blood lymphocytes in Parkinson’s diseaseNeuroreport1029071010549795
   PubMed Web of Science ®Google Scholar
• CarontiBAntoniniGCalderaroC2001Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson’s diseaseJ Neural Transm108803711515746
   PubMed Web of Science ®Google Scholar
• ChaudhuriKR2001Autonomic dysfunction in movement disordersCurr Opin Neurol145051111470968
   PubMed Web of Science ®Google Scholar
• ChaudhuriKR2003Noctural symptom complex in PD and its managementNeurology61 Suppl 3S17S2314504376
   PubMed Web of Science ®Google Scholar
• DoderMRabinerEATurjanskiN2000Brain serotonin 5HT1A receptors in Parkinson’s disease with and without depression measured by positron emission tomography with 11C-WAY 10635Mov Disord15213
   Google Scholar
• DotyRLDeemsDAStellarS1988Olfactory dysfunction in parkinsonism:a general deficit unrelated to neurological signs, disease stage, or disease durationNeurology391237443399075
   PubMed Web of Science ®Google Scholar
• DotyRLSternMBPfeifferC1992Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson‘s diseaseJ Neurol Neurosurg Psychiatry55138421538221
   PubMed Web of Science ®Google Scholar
• DotyRLGolbeLIMcKeownDA1993Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson’s diseaseNeurology4396258492953
   PubMed Web of Science ®Google Scholar
• EisensehrILinkeRNoatcharS2000Reduced striatal dopamine transporter in idiopathic rapid eye movement sleep behavior disorder:comparison with Parkinson‘s disease and controlsBrain12311556010825354
   PubMed Web of Science ®Google Scholar
• EckertTEidelbergD2005Neuroimaging and therapeutics in movement disordersNeuroRx23617115897956
   PubMedGoogle Scholar
• GagnonJFBedardMAFantiniML2002REM sleep behavior disorder and REM sleep without atonia in Parkinson’s diseaseNeurology59585912196654
   PubMed Web of Science ®Google Scholar
• GoldsteinDSHolmesCLiST2000Cardiac sympathetic denervation in Parkinson’s diseaseAnn Intern Med1333384710979878
   PubMed Web of Science ®Google Scholar
• GotzMEGerstnerAHarthR2000Altered redox state of platelet coenzyme Q10 in Parkinson’s diseaseJ Neural Transm10741810809402
   PubMed Web of Science ®Google Scholar
• HawkesCHShephardBCDanielSE1997Olfactory dysfunction in Parkinson’s diseaseJ Neurol Neurosurg Psychiatry62436469153598
   PubMed Web of Science ®Google Scholar
• HawkesCH2006Olfaction in neurodegenerative disordersActa Otorhinolaryngol6313351
   Google Scholar
• HolthoffVAViereggePKesslerJ1994Discordant twins with Parkinson’s disease:positron emission tomography and early signs of impaired cognitive circuitsAnn Neurol36176828053653
   PubMed Web of Science ®Google Scholar
• HoytBD2005Sleep in patients with neurologic and psychiatric disordersPrim Care325354815935199
   PubMed Web of Science ®Google Scholar
• HughesAJDanielSEKilfordL1992Accuracy of clinical diagnosis of idiopathic Parkinson’s disease:a clinico-pathological study of 100 casesJ Neurol Neurosurg Psychiatry5518141564476
   PubMed Web of Science ®Google Scholar
• IdiaquezJSandovalESeguelA2002Association between neuropsychiatric and autonomic dysfunction in Alzheimer’s diseaseClin Auton Res1243612102448
   PubMed Web of Science ®Google Scholar
• IlicTVJovanovicMJovicicA1999Oxidative stress indicators are elevated in de novo Parkinson’s disease patientsFunct Neurol1414114710568214
   PubMed Web of Science ®Google Scholar
• JennerP2003Oxidative stress in Parkinson’s diseaseAnn Neurol53 Suppl 3S26S3612666096
   PubMed Web of Science ®Google Scholar
• KikuchiATakedaAOnoderaH2002Systemic increase of oxidative nucleic acid damage in Parkinson’s disease and multiple system atrophyNeurobiol Dis924424811895375
   PubMed Web of Science ®Google Scholar
• KlockgetherT2004Parkinson’s disease:clinical aspectsCell Tissue Res3181152015365814
   PubMed Web of Science ®Google Scholar
• LauterbachECFreemanAVogelRL2004Differential DSM-III psychiatric disorder prevalence profiles in dystonia and Parkinson‘s diseaseJ Neuropsychiatry Clin Neurosci16293614990756
   PubMed Web of Science ®Google Scholar
• LahinenARuottinenHRinneOJ2000Risk for Parkinson’s disease: twin studies for the detection of asymptomatic subjects using [18F]6-fluorodopa PETJ Neurol247Suppl 2II11011310991657
   PubMedGoogle Scholar
• MagerkurthCSchnitzerRBrauneS2005Symptoms of autonomic failure in Parkinson‘s disease:prevalence and impact on daily lifeClin Auton Res15768215834763
   PubMed Web of Science ®Google Scholar
• MarekKInnisRVan DyckC2001[123I]-beta-CIT-SPECT imaging assessment of the rate of Parkinson’s disease progressionNeurology5720899411739831
   PubMed Web of Science ®Google Scholar
• MarkopoulouKLarsenKWWszolekEK1997Olfactory dysfunction in familial parkinsonismNeurology49126279371905
   PubMed Web of Science ®Google Scholar
• MicieliGTosiPMarcheselliS2003Autonomic dysfunction in Parkinson’s diseaseNeurol Sci24 Suppl 1S32S3412774210
   PubMed Web of Science ®Google Scholar
• MullerAReichmannHLivermoreA2002Olfactory function in idiopathic Parkinson’s disease (IPD):results from cross-sectional studies in IPD patients and long-term follow-up of de novo-IPD patientsJ Neural Transm1098051112111470
   PubMed Web of Science ®Google Scholar
• NagaiYUenoSSaekiY1996Decrease of the D3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson’s diseaseNeurology4679158618685
   PubMed Web of Science ®Google Scholar
• NiehausLSavyerNWeberU2004Brain parenchyma sonography in patients with essential tremor and Parkinson‘s diseaseCerebrovasc Dis17Suppl 43
   Google Scholar
• NilssonFMKessigLVBolwigTG2001Increased risk of developing Parkinson’s disease for patients with major affective disordersActa Psychiatr Scand104380611722320
   PubMed Web of Science ®Google Scholar
• OlsonEJBoeveBFSilberMH2000Rapid eye movement sleep behavior disorder:demographic, clinical and laboratory findings in 93 casesBrain12338893
   Web of Science ®Google Scholar
• ParkerWDJrBoysonSJParksJK1989Abnormalities of the electron transport chain in idiopathic Parkinson’s diseaseAnn Neurol26719232557792
   PubMed Web of Science ®Google Scholar
• Parkinson Study Group2000Pramipexole versus levodopa as initial treatment for Parkinson disease:a randomized controlled trialJAMA2841931811035889
   PubMed Web of Science ®Google Scholar
• PicciniPMorrishPKTurjanskiN1997Dopaminergic function in familial Parkinson’s disease:a clinical and 18F-dopa positron emission tomography studyAnn Neurol4122299029071
   PubMed Web of Science ®Google Scholar
• PonsenMMStoffersDBooijJ2004Idiopathic hyposmia as a preclinical sign of Parkinson’s diseaseAnn Neurol561738115293269
   PubMed Web of Science ®Google Scholar
• RascolOGoetzCKollerW2002Treatment interventions for Parkinson’s disease:an evidence based assessmentLancet35915899812047983
   PubMed Web of Science ®Google Scholar
• RemyPDoderMLeesA2005Depression in Parkinson’s disease: loss of dopamine and noradrenaline innervation in the limbic systemBrain12813142215716302
   PubMed Web of Science ®Google Scholar
• SaperCChouTCScammellTE2001The sleep switch:hypothalamic control of sleep and wakefulnessTrends Neurosci247263111718878
   PubMed Web of Science ®Google Scholar
• SchenkCHBundlieSRMahowaldMW1996Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorderNeurology46388938614500
   PubMed Web of Science ®Google Scholar
• SchurmannAGVan Den AkkerHEnsinckKTJL2002Increased risk of Parkinson‘s disease after depression:a retrospective cohort studyNeurology581501412034786
   PubMed Web of Science ®Google Scholar
• SchwarzJLinkeRKernerM2000Striatal dopamine transporter binding assessed by [123I]IPT and single photon emission computed tomography in patients with early Parkinson’s disease: implications for a preclinical diagnosisArch Neurol57205810681078
   PubMedGoogle Scholar
• ShapiraAHCooperJMDexterD1990Mitochondrial complex I deficiency in Parkinson’s diseaseJ Neurochem5482372154550
   PubMed Web of Science ®Google Scholar
• ShibaMBowerJHMaraganoreDM2000Anxiety disorders and depressive disorders preceding Parkinson’s disease:a case-control studyMov Disord156697710928577
   PubMed Web of Science ®Google Scholar
• SingletonAGwinn-HardyKSharabiY2004Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplicationBrain1277687214736756
   PubMed Web of Science ®Google Scholar
• SommerUHummelTCormannK2004Detection of presymptomatic Parkinson’s disease:combinating smell tests, transcranial sonography, and SPECTMov Disord19119620215390014
   PubMed Web of Science ®Google Scholar
• Stiasny-KolsterKDoerrYMollerJC2005Combination of idiopathic REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECTBrain1281263715548552
   PubMed Web of Science ®Google Scholar
• TissinghGBerendseHWBergmansP2001Loss of olfaction in de novo and treated Parkinson’s disease:possible implications for early diagnosisMov Disord1641611215591
   PubMed Web of Science ®Google Scholar
• TracikFEbersbachG2001Sudden daytime sleep onset in Parkinson’s disease:polysomnographic recordingsMov Disord16500611391745
   PubMed Web of Science ®Google Scholar
• WalterUWittstockMBeneckeR2002Substantia nigra hecogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson‘s diseaseJ Neural Transm109191612075859
   PubMed Web of Science ®Google Scholar
• WalterUNiehausLProbstT2003Brain parenchyma sonography discriminates Parkinson‘s disease and atypical parkinsonian syndromesNeurology6074712525721
   PubMed Web of Science ®Google Scholar
• WalterUKleinCHilkerR2004Deep brain parenchyma sonography detects preclinical parkinsonismMov Disord191445915390070
   PubMed Web of Science ®Google Scholar
• WeisskopfMGChenHSchwarzchildMA2003Prospective study of phobic anxiety and risk of Parkinson‘s diseaseMov Disord186465112784267
   PubMed Web of Science ®Google Scholar
• WenningGKShepardBHawkesC1995Olfactory function in atypical parkinsonian syndromesActa Neurol Scand91247507625148
   PubMed Web of Science ®Google Scholar
• WhoneALWattsRLStoesslAJ2003Slower progression of Parkinson’s disease with ropinirole versus levodopa:the REAL-PET studyAnn Neurol549310112838524
   PubMed Web of Science ®Google Scholar
• WoltersECFrancotCBergmansP2000Preclinical (premotor) Parkinson’s diseaseJ Neurol247suppl 2II103910991655
   PubMedGoogle Scholar
• ZeddeMMancaABauleG2005Brain parenchyma sonography (BPS) of substantia nigra (SN) in Parkinson’s diseaseParkinsonism & Rel Dis11Suppl 2222
   Google Scholar